BARCLAYS PLC

Position in MESO — Mesoblast Ltd

CIK 312069 LONDON, X0

Position in MESO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$41,157

+$21,440 QoQ

Shares Held

3,042

+137.3% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#45

of 72 holders

Holding Since

Jun 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $1,710,275,600 across 455 Biotechnology names. MESO ranks #284 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	733,274	$364,239,192
2	REGN	Regeneron Pharmaceuticals, Inc.	256,192	$159,745,957
3	IONS	Ionis Pharmaceuticals Inc	1,603,136	$127,112,653
4	ARGX	Argenx SE	134,427	$124,717,337
5	MRNA	Moderna, Inc.	1,035,126	$72,489,872
6	BBIO	BridgeBio Pharma, Inc.	714,423	$53,210,224
7	TGTX	Tg Therapeutics, Inc.	957,848	$52,624,168
8	DNTH	Dianthus Therapeutics, Inc. /DE/	431,753	$42,087,281

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$41,157	3,042	+137.3%	Shares	Defined	2026-08-14
2026-03-31	$19,717	1,282	+8.6%	Shares	Defined	2026-05-15
2025-12-31	$21,287	1,180	+118.1%	Shares	Sole	2026-02-13
2025-09-30	$8,715	541	-84.9%	Shares	Sole	2026-03-31
2025-06-30	$38,888	3,571	+39.7%	Shares	Sole	2026-02-27
2025-03-31	$31,911	2,557	+34.6%	Shares	Sole	2026-03-17
2024-12-31	$37,620	1,900	+5035.1%	Shares	Sole	2026-03-19
2021-09-30	$222	37	-99.7%	Shares	Sole	2021-11-09
2021-06-30	$97,240	13,000	+1344.4%	Shares	Sole	2021-08-13
2021-03-31	$7,443	900	-52.6%	Shares	Sole	2021-05-13
2020-12-31	$16,131	1,900	-84.0%	Shares	Sole	2021-02-11
2020-09-30	$221,221	11,900	+1222.2%	Shares	Sole	2020-11-12
2020-06-30	$10,251	900	—	Shares	Sole	2020-08-12
No filing history on record for this holder in this stock.